Correlation Between Veracyte and Novo Nordisk
Can any of the company-specific risk be diversified away by investing in both Veracyte and Novo Nordisk at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Veracyte and Novo Nordisk into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Veracyte and Novo Nordisk AS, you can compare the effects of market volatilities on Veracyte and Novo Nordisk and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Veracyte with a short position of Novo Nordisk. Check out your portfolio center. Please also check ongoing floating volatility patterns of Veracyte and Novo Nordisk.
Diversification Opportunities for Veracyte and Novo Nordisk
-0.76 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Veracyte and Novo is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding Veracyte and Novo Nordisk AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novo Nordisk AS and Veracyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Veracyte are associated (or correlated) with Novo Nordisk. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novo Nordisk AS has no effect on the direction of Veracyte i.e., Veracyte and Novo Nordisk go up and down completely randomly.
Pair Corralation between Veracyte and Novo Nordisk
Given the investment horizon of 90 days Veracyte is expected to generate 1.59 times more return on investment than Novo Nordisk. However, Veracyte is 1.59 times more volatile than Novo Nordisk AS. It trades about 0.3 of its potential returns per unit of risk. Novo Nordisk AS is currently generating about -0.16 per unit of risk. If you would invest 3,412 in Veracyte on August 28, 2024 and sell it today you would earn a total of 698.00 from holding Veracyte or generate 20.46% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Veracyte vs. Novo Nordisk AS
Performance |
| Timeline |
| Veracyte |
| Novo Nordisk AS |
Veracyte and Novo Nordisk Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Veracyte and Novo Nordisk
The main advantage of trading using opposite Veracyte and Novo Nordisk positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Veracyte position performs unexpectedly, Novo Nordisk can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novo Nordisk will offset losses from the drop in Novo Nordisk's long position.| Veracyte vs. Crinetics Pharmaceuticals | Veracyte vs. Viridian Therapeutics | Veracyte vs. Cytokinetics | Veracyte vs. Structure Therapeutics American |
| Novo Nordisk vs. Regeneron Pharmaceuticals | Novo Nordisk vs. Crispr Therapeutics AG | Novo Nordisk vs. Sarepta Therapeutics | Novo Nordisk vs. Intellia Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |